Literature DB >> 2672556

Current models in pharmacokinetics: applications in veterinary pharmacology.

L D Kinabo1, Q A McKellar.   

Abstract

Major advances in developing models for pharmacokinetic studies have been made in recent years, and different approaches can now be employed. These include the use of (1) compartmental models, (2) non-compartmental models, (3) physiological models, (4) population pharmacokinetic models, and (5) pharmacokinetic-pharmacodynamic models. Each of these approaches has both advantages and disadvantages. The important question of which of these is 'ideal' in veterinary pharmacokinetics has no simple answer. The selection and application of any one approach would depend on a number of factors, such as (1) the purpose of the study, (2) physicochemical properties and actions of the drug, (3) specificity and sensitivity of the analytical methodology, (4) species of the animal, and (5) availability of funds. This paper reviews the models available for pharmacokinetic studies and indicates their possible application in veterinary pharmacology.

Mesh:

Year:  1989        PMID: 2672556     DOI: 10.1007/bf00346724

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  68 in total

1.  Solid-phase extraction and ion-pair reversed-phase HPLC of isometamidium in bovine serum and tissues.

Authors:  L D Kinabo; J A Bogan
Journal:  Acta Trop       Date:  1988-06       Impact factor: 3.112

Review 2.  Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Authors:  D P Vaughan; I Hope
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

3.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 4.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

5.  Simultaneous pharmacokinetic and pharmacodynamic modeling.

Authors:  W A Colburn
Journal:  J Pharmacokinet Biopharm       Date:  1981-06

6.  Pharmacokinetics of gentamicin after intravenous, intramuscular, and subcutaneous administration in cats.

Authors:  A D Jernigan; R C Wilson; R C Hatch; D T Kemp
Journal:  Am J Vet Res       Date:  1988-01       Impact factor: 1.156

7.  Bioavailability of four slow-release theophylline formulations in the beagle dog.

Authors:  G D Koritz; B C McKiernan; C A Neff-Davis; I J Munsiff
Journal:  J Vet Pharmacol Ther       Date:  1986-09       Impact factor: 1.786

8.  Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.

Authors:  P Lees; T Ayliffe; T E Maitho; J B Taylor
Journal:  Res Vet Sci       Date:  1988-01       Impact factor: 2.534

9.  The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.

Authors:  L B Sheiner
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

10.  Sulfatroxazole: pharmacokinetics, metabolism and urinary excretion in goats and pigs.

Authors:  L D Kinabo; P Nielsen
Journal:  J Vet Pharmacol Ther       Date:  1986-03       Impact factor: 1.786

View more
  1 in total

1.  Frequency of diminazene-resistant trypanosomes in populations of Trypanosoma congolense arising in infected animals following treatment with diminazene aceturate.

Authors:  M Mamman; G Gettinby; N B Murphy; S Kemei; A S Peregrine
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.